Opinion: Getting contraceptives for men to the market will take pharma’s help
The potential for male contraception is huge. So why isn't the pharmaceutical industry interested in developing them?
by Régine Sitruk-Ware
May 11, 2018
3 minutes
That the responsibility for preventing unintended pregnancy still lies almost exclusively with women remains one of the world’s great health inequities. Beyond condom use, vasectomy, and withdrawal, there are no other male-controlled methods of contraception, even though it’s an entirely feasible option. One of the biggest obstacles to the development of male contraceptives has been the lack of interest and involvement from pharmaceutical companies.
At a time when more governments are restricting access to female contraception, expanding male contraceptive options could help to make family
You’re reading a preview, subscribe to read more.
Start your free 30 days